Hepatitis B virus genetic variability and evolution

Virus Research

Volumn 127, Issue 2, 2007, Pages 164-176

  Kay, Alan ^a,b   Zoulim, Fabien ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HÔTEL DIEU   (France)

Author keywords

Evolution; Genetics; Genotypes; HBV; Mutations; Serotypes

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; EMTRICITABINE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; PEGINTERFERON; TELBIVUDINE; TENOFOVIR;

ARTICLE; GENE MUTATION; GENETIC ORGANIZATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; VACCINATION; VIRUS RECOMBINATION;

EVOLUTION, MOLECULAR; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MUTATION; RECOMBINATION, GENETIC; VARIATION (GENETICS);

HEPATITIS B VIRUS;

EID: 34447500303     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.02.021     Document Type: Article

References (117)

1. Akarca U.S., and Lok A.S. Naturally occurring core-gene-defective hepatitis B viruses. J. Gen. Virol. 76 Pt 7 (1995) 1821-1826
2. Alestig E., Hannoun C., Horal P., and Lindh M. Phylogenetic origin of hepatitis B virus strains with precore C-1858 variant. J. Clin. Microbiol. 39 9 (2001) 3200-3203
3. Alexopoulou A., Karayiannis P., Hadziyannis S.J., Aiba N., and Thomas H.C. Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species. J. Hepatol. 26 4 (1997) 748-753
4. Allen M.I., Deslauriers M., Andrews C.W., Tipples G.A., Walters K.A., Tyrell D.L.J., Brown N., and Condreay L.D. Identification and characterization of mutations in hepatitis B virus resistant to Lamivudine. Hepatology 27 (1998) 1670-1677
5. Angus P., Vaughan R., Xiong S., Yang H., Delaney W., Gibbs C., Brosgart C., Colledge D., Edwards R., Ayres A., Bartholomeusz A., and Locarnini S. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125 2 (2003) 292-297
6. Arauz-Ruiz P., Norder H., Robertson B.H., and Magnius L.O. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol. 83 Pt 8 (2002) 2059-2073
7. Bartholomeusz A., Tehan B.G., and Chalmers D.K. Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir. Ther. 9 2 (2004) 149-160
8. Bartholomew M.M., Jansen R.W., Jeffers L.J., Reddy K.R., Johnson L.C., Bunzendahl H., Condreay L.D., Tzakis A.G., Schiff E.R., and Brown N.A. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349 9044 (1997) 20-22
9. Baumert T.F., Rogers S.A., Hasegawa K., and Liang T.J. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J. Clin. Invest. 98 10 (1996) 2268-2276
10. Bock C.T., Tillmann H.L., Maschek H.J., Manns M.P., and Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 113 6 (1997) 1976-1982
11. Bouvier G.L., and Williams A. Serotypes of hepatitis B antigen (HBs Ag): the problem of "new" determinants, as exemplified by "t". Am. J. Med. Sci. 270 1 (1975) 165-171
12. Buckwold V.E., Xu Z., Yen T.S., and Ou J.H. Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J. Gen. Virol. 78 Pt 8 (1997) 2055-2065
13. Carman W.F., Jacyna M.R., Hadziyannis S., Karayiannis P., McGarvey M.J., Makris A., and Thomas H.C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2 8663 (1989) 588-591
14. Carman W.F., Korula J., Wallace L., MacPhee R., Mimms L., and Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA [see comments]. Lancet 345 8962 (1995) 1406-1407
15. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A.J., and Thomas H.C. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336 8711 (1990) 325-329
16. Casey J.L., Niro G.A., Engle R.E., Vega A., Gomez H., McCarthy M., Watts D.M., Hyams K.C., and Gerin J.L. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J. Infect. Dis. 174 5 (1996) 920-926
17. Chen I.H., Huang C.J., and Ting L.P. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J. Virol. 69 6 (1995) 3647-3657
18. Chudy M., Schmidt M., Czudai V., Scheiblauer H., Nick S., Mosebach M., Hourfar M.K., Seifried E., Roth W.K., Grunelt E., and Nubling C.M. Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology 44 1 (2006) 99-107
19. Cooreman M.P., Leroux-Roels G., and Paulij W.P. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 8 3 (2001) 237-247
20. Cooreman M.P., van Roosmalen M.H., te Morsche R., Sunnen C.M., de Ven E.M., Jansen J.B., Tytgat G.N., de Wit P.L., and Paulij W.P. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations. Hepatology 30 5 (1999) 1287-1292
21. Courouce A.M., Lee H., Drouet J., Canavaggio M., and Soulier J.P. Monoclonal antibodies to HBsAg: a study of their specificities for eight different HBsAg subtypes. Dev. Biol. Stand. 54 (1983) 527-534
22. Das K., Xiong X., Yang H., Westland C.E., Gibbs C.S., Sarafianos S.G., and Arnold E. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J. Virol. 75 10 (2001) 4771-4779
23. Delaney W.E.t., Ray A.S., Yang H., Qi X., Xiong S., Zhu Y., and Miller M.D. Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus. Antimicrob. Agents Chemother. 50 7 (2006) 2471-2477
24. Delaney W.E.t., Yang H., Westland C.E., Das K., Arnold E., Gibbs C.S., Miller M.D., and Xiong S. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J. Virol. 77 21 (2003) 11833-11841
25. Devesa M., Rodriguez C., Leon G., Liprandi F., and Pujol F.H. Clade analysis and surface antigen polymorphism of hepatitis B virus American genotypes. J. Med. Virol. 72 3 (2004) 377-384
26. Ding X., Mizokami M., Yao G., Xu B., Orito E., Ueda R., and Nakanishi M. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 44 1 (2001) 43-47
27. Fernholz D., Galle P.R., Stemler M., Brunetto M., Bonino F., and Will H. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194 1 (1993) 137-148
28. Fiordalisi G., Cariani E., Mantero G., Zanetti A., Tanzi E., Chiaramonte M., and Primi D. High genomic variability in the pre-C region of hepatitis B virus in anti-HBe, HBV DNA-positive chronic hepatitis. J. Med. Virol. 31 4 (1990) 297-300
29. Fiordalisi G., Primi D., Tanzi E., Magni E., Incarbone C., Zanetti A.R., and Cariani E. Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers. J. Med. Virol. 42 2 (1994) 109-114
30. Friedt M., Gerner P., Lausch E., Trubel H., Zabel B., and Wirth S. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 29 4 (1999) 1252-1258
31. Galibert F., Chen T.N., and Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with hepatitis B virus sequence. J. Virol. 41 (1982) 51-65
32. Galibert F., Mandart E., Fitoussi F., Tiollais P., and Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 280 (1979) 646-650
33. Ganem D., and Schneider R. Hepadnaviridae: the viruses and their replication. In: Knipe D., Howley P., Griffin D., Lamb R., Martin M., Roizman B., and Strauss S. (Eds). Fields virology. fourth ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA 2923-2969
34. Gerner P.R., Friedt M., Oettinger R., Lausch E., and Wirth S. The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children. Virology 245 1 (1998) 163-172
35. Ghany M.G., Ayola B., Villamil F.G., Gish R.G., Rojter S., Vierling J.M., and Lok A.S. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27 1 (1998) 213-222
36. Grethe S., Heckel J.O., Rietschel W., and Hufert F.T. Molecular epidemiology of hepatitis B virus variants in nonhuman primates. J. Virol. 74 11 (2000) 5377-5381
37. Grethe S., Monazahian M., Bohme I., and Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J. Virol. 72 9 (1998) 7692-7696
38. Gunther S., Paulij W., Meisel H., and Will H. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Virology 244 1 (1998) 146-160
39. Gunther S., Piwon N., Iwanska A., Schilling R., Meisel H., and Will H. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J. Virol. 70 12 (1996) 8318-8331
40. Hadziyannis S.J., Lieberman H.M., Karvountzis G.G., and Shafritz D.A. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology 3 5 (1983) 656-662
41. Hasegawa K., Huang J., Rogers S.A., Blum H.E., and Liang T.J. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J. Virol. 68 3 (1994) 1651-1659
42. Hou J.L., Karayiannis P., Waters J., Luo K.X., Liang C.S., and Thomas H.C. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 21 2 (1995) 273-278
43. Hsu H.Y., Chang M.H., Ni Y.H., and Chen H.L. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53 10 (2004) 1499-1503
44. Hsu H.Y., Chang M.H., Ni Y.H., Lin H.H., Wang S.M., and Chen D.S. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26 3 (1997) 786-791
45. Huy T.T., Ushijima H., Quang V.X., Win K.M., Luengrojanakul P., Kikuchi K., Sata T., and Abe K. Genotype C of hepatitis B virus can be classified into at least two subgroups. J. Gen. Virol. 85 Pt 2 (2004) 283-292
46. Ilan E., Burakova T., Dagan S., Nussbaum O., Lubin I., Eren R., Ben-Moshe O., Arazi J., Berr S., Neville L., Yuen L., Mansour T.S., Gillard J., Eid A., Jurim O., Shouval D., Reisner Y., and Galun E. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 29 2 (1999) 553-562
47. Ireland J.H., O'Donnell B., Basuni A.A., Kean J.D., Wallace L.A., Lau G.K., and Carman W.F. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31 5 (2000) 1176-1182
48. Janssen H.L., van Zonneveld M., Senturk H., Zeuzem S., Akarca U.S., Cakaloglu Y., Simon C., So T.M., Gerken G., de Man R.A., Niesters H.G., Zondervan P., Hansen B., and Schalm S.W. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365 9454 (2005) 123-129
49. Kalinina T., Iwanski A., Will H., and Sterneck M. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38 5 (2003) 1274-1281
50. Kao J.H., Chen P.J., Lai M.Y., and Chen D.S. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118 3 (2000) 554-559
51. Kessler H.H., Preininger S., Stelzl E., Daghofer E., Santner B.I., Marth E., Lackner H., and Stauber R.E. Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin. Diagn. Lab. Immunol. 7 2 (2000) 298-300
52. Kobayashi M., Arase Y., Ikeda K., Tsubota A., Suzuki Y., Saitoh S., Kobayashi M., Suzuki F., Akuta N., Someya T., Matsuda M., Sato J., Takagi K., Miyakawa Y., and Kumada H. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan. J. Med. Virol. 68 4 (2002) 522-528
53. Lacombe K., Massari V., Girard P.M., Serfaty L., Gozlan J., Pialoux G., Mialhes P., Molina J.M., Lascoux-Combe C., Wendum D., Carrat F., and Zoulim F. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. Aids 20 3 (2006) 419-427
54. Lai C.L., Leung N., Teo E.K., Tong M., Wong F., Hann H.W., Han S., Poynard T., Myers M., Chao G., Lloyd D., and Brown N.A. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B. Gastroenterology 129 2 (2005) 528-536
55. Lanford R.E., Chavez D., Brasky K.M., Burns R.B., and RicoHesse R. Isolation of a hepadnavirus from the woolly monkey, a new world primate. Proc. Natl. Acad. Sci. U.S.A. 95 10 (1998) 5757-5761
56. Li J., Buckwold V.E., Hon M.W., and Ou J.H. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J. Virol. 73 2 (1999) 1239-1244
57. Liang T.J., Hasegawa K., Rimon N., Wands J.R., and Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N. Engl. J. Med. 324 24 (1991) 1705-1709
58. Mandart E., Kay A., and Galibert F. Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J. Virol. 49 (1984) 782-792
59. Mayerat C., Mantegani A., and Frei P.C. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?. J. Viral. Hepat. 6 4 (1999) 299-304
60. Melegari M., Bruno S., and Wands J.R. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 199 2 (1994) 292-300
61. Milich D., and Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38 5 (2003) 1075-1086
62. Mizokami M., Orito E., Ohba K., Ikeo K., Lau J.Y.N., and Gojobori T. Constrained evolution with respect to gene overlap of hepatitis B virus. J. Mol. Evol. 44 (1997) S83-S90
63. Moriyama K., Okamoto H., Tsuda F., and Mayumi M. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226 2 (1996) 269-280
64. Naumann H., Schaefer S., Yoshida C.F.T., Gaspar A.M.C., Repp R., and Gerlich W.H. Identification of a new hepatitis-B-virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. J. Gen. Virol. 74 Part 8 (1993) 1627-1632
65. Neurath A.R., Kent S.B., Strick N., and Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46 3 (1986) 429-436
66. Ni Y.H., Chang M.H., Hsu H.Y., and Chen H.L. Long-term follow-up study of core gene deletion mutants in children with chronic hepatitis B virus infection. Hepatology 32 1 (2000) 124-128
67. Norder H., Courouce A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., Robertson B.H., Locarnini S., and Magnius L.O. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HB(s)Ag subtypes. Intervirology 47 6 (2004) 289-309
68. Norder H., Courouce A.M., and Magnius L.O. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J. Gen. Virol. 73 Pt 12 (1992) 3141-3145
69. Norder H., Courouce A.M., and Magnius L.O. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198 2 (1994) 489-503
70. Norder H., Ebert J.W., Fields H.A., Mushahwar I.K., and Magnius L.O. Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology 218 1 (1996) 214-223
71. Norder H., Hammas B., Lofdahl S., Courouce A.M., and Magnius L.O. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J. Gen. Virol. 73 Pt 5 (1992) 1201-1208
72. Ohba K.I., Mizokami M., Ohno T., Suzuki K., Orito E., Lau J.Y.N., Ina Y., Ikeo K., and Gojobori T. Relationships between serotypes and genotypes of hepatitis B virus: genetic classification of HBV by use of surface genes. Virus Res. 39 1 (1995) 25-34
73. Okamoto H., Imai M., Tsuda F., Tanaka T., Miyakawa Y., and Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J. Virol. 61 10 (1987) 3030-3034
74. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., and Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 68 12 (1994) 8102-8110
75. Okamoto H., Tsuda F., Sakugawa H., Sastrosoewignjo R.I., Imai M., Miyakawa Y., and Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol. 69 Pt 10 (1988) 2575-2583
76. Okamoto H., Yano K., Nozaki Y., Matsui A., Miyazaki H., Yamamoto K., Tsuda F., Machida A., and Mishiro S. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr. Res. 32 3 (1992) 264-268
77. Okamoto H., Yotsumoto S., Akahane Y., Yamanaka T., Miyazaki Y., Sugai Y., Tsuda F., Tanaka T., Miyakawa Y., and Mayumi M. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J. Virol. 64 3 (1990) 1298-1303
78. Okumura A., Takayanagi M., Aiyama T., Iwata K., Wakita T., Ishikawa T., Yoshioka K., and Kakumu S. Serial analysis of hepatitis B virus core nucleotide sequence of patients with acute exacerbation during chronic infection. J. Med. Virol. 49 2 (1996) 103-109
79. Oon C.J., and Chen W.N. Current aspects of hepatitis B surface antigen mutants in Singapore. J. Viral. Hepat. 5 Suppl. 2 (1998) 17-23
80. Oon C.J., Chen W.N., Goo K.S., and Goh K.T. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. J. Infect. 41 3 (2000) 260-264
81. Oon C.J., Chen W.N., Koh S., and Lim G.K. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J. Infect. Dis. 179 1 (1999) 259-263
82. Parekh S., Zoulim F., Ahn S.H., Tsai A., Li J., Kawai S., Khan N., Trepo C., Wands J., and Tong S. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J. Virol. 77 12 (2003) 6601-6612
83. Persson B., and Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J. Mol. Biol. 237 2 (1994) 182-192
84. Protzer-Knolle U., Naumann U., Bartenschlager R., Berg T., Hopf U., Meyer zum Buschenfelde K.H., Neuhaus P., and Gerken G. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27 1 (1998) 254-263
85. Pult I., Abbott N., Zhang Y.Y., and Summers J. Frequency of spontaneous mutations in an avian hepadnavirus infection. J. Virol. 75 20 (2001) 9623-9632
86. Quintero A., Uzcategui N., Loureiro C.L., Villegas L., Illarramendi X., Guevara M.E., Ludert J.E., Blitz L., Liprandi F., and Pujol F.H. Hepatitis delta virus genotypes I and III circulate associated with hepatitis B virus genotype F in Venezuela. J. Med. Virol. 64 3 (2001) 356-359
87. Raimondo G., Schneider R., Stemler M., Smedile V., Rodino G., and Will H. A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis. Virology 179 1 (1990) 64-68
88. Sanchez-Tapias J.M., Costa J., Mas A., Bruguera M., and Rodes J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123 6 (2002) 1848-1856
89. Santantonio T., Jung M.C., Schneider R., Fernholz D., Milella M., Monno L., Pastore G., Pape G.R., and Will H. Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology 188 2 (1992) 948-952
90. Sato S., Suzuki K., Akahane Y., Akamatsu K., Akiyama K., Yunomura K., Tsuda F., Tanaka T., Okamoto H., Miyakawa Y., and Mayumi M. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann. Intern. Med. 122 4 (1995) 241-248
91. Scaglioni P.P., Melegari M., and Wands J.R. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233 2 (1997) 374-381
92. Sheldon J., Camino N., Rodes B., Bartholomeusz A., Kuiper M., Tacke F., Nunez M., Mauss S., Lutz T., Klausen G., Locarnini S., and Soriano V. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir. Ther. 10 6 (2005) 727-734
93. Stevens C.E., Neurath R.A., Beasley R.P., and Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J. Med. Virol. 3 3 (1979) 237-241
94. Stuyver L., De Gendt S., Van Geyt C., Zoulim F., Fried M., Schinazi R.F., and Rossau R. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J. Gen. Virol. 81 Pt 1 (2000) 67-74
95. Stuyver L.J., Locarnini S.A., Lok A., Richman D.D., Carman W.F., Dienstag J.L., and Schinazi R.F. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 33 3 (2001) 751-757
96. Sugauchi F., Kumada H., Acharya S.A., Shrestha S.M., Gamutan M.T., Khan M., Gish R.G., Tanaka Y., Kato T., Orito E., Ueda R., Miyakawa Y., and Mizokami M. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J. Gen. Virol. 85 Pt 4 (2004) 811-820
97. Sugauchi F., Kumada H., Sakugawa H., Komatsu M., Niitsuma H., Watanabe H., Akahane Y., Tokita H., Kato T., Tanaka Y., Orito E., Ueda R., Miyakawa Y., and Mizokami M. Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan. Clin. Infect. Dis. 38 9 (2004) 1222-1228
98. Sumi H., Yokosuka O., Seki N., Arai M., Imazeki F., Kurihara T., Kanda T., Fukai K., Kato M., and Saisho H. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 37 1 (2003) 19-26
99. Sung J.J., Wong M.L., Bowden S., Liew C.T., Hui A.Y., Wong V.W., Leung N.W., Locarnini S., and Chan H.L. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 128 7 (2005) 1890-1897
100. Takahashi K., Akahane Y., Hino K., Ohta Y., and Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch. Virol. 143 12 (1998) 2313-2326
101. Tenney D.J., Levine S.M., Rose R.E., Walsh A.W., Weinheimer S.P., Discotto L., Plym M., Pokornowski K., Yu C.F., Angus P., Ayres A., Bartholomeusz A., Sievert W., Thompson G., Warner N., Locarnini S., and Colonno R.J. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob. Agents Chemother. 48 9 (2004) 3498-3507
102. Thakur V., Kazim S.N., Guptan R.C., Hasnain S.E., Bartholomeusz A., Malhotra V., and Sarin S.K. Transmission of G145R mutant of HBV to an unrelated contact. J. Med. Virol. 76 1 (2005) 40-46
103. Thibault V., Aubron-Olivier C., Agut H., and Katlama C. Primary infection with a lamivudine-resistant hepatitis B virus. Aids 16 1 (2002) 131-133
104. Tong S.P., Li J.S., Vitvitski L., Kay A., and Treepo C. Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J. Virol. 67 9 (1993) 5651-5655
105. Tong S.P., Li J.S., Vitvitski L., and Trepo C. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology 176 2 (1990) 596-603
106. Tong S.P., Li J.S., Vitvitski L., and Trepo C. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal. Virology 191 1 (1992) 237-245
107. Torresi J., Earnest-Silveira L., Deliyannis G., Edgtton K., Zhuang H., Locarnini S.A., Fyfe J., Sozzi T., and Jackson D.C. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293 2 (2002) 305-313
108. Vieth S., Manegold C., Drosten C., Nippraschk T., and Gunther S. Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany. Virus Genes 24 2 (2002) 153-156
109. Villeneuve J.P., Durantel D., Durantel S., Westland C., Xiong S., Brosgart C.L., Gibbs C.S., Parvaz P., Werle B., Trepo C., and Zoulim F. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. J. Hepatol. 39 6 (2003) 1085-1089
110. Warren K.S., Heeney J.L., Swan R.A., Heriyanto, and Verschoor E.J. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus). J. Virol. 73 9 (1999) 7860-7865
111. Werle-Lapostolle B., Bowden S., Locarnini S., Wursthorn K., Petersen J., Lau G., Trepo C., Marcellin P., Goodman Z., Delaney W.E.t., Xiong S., Brosgart C.L., Chen S.S., Gibbs C.S., and Zoulim F. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126 7 (2004) 1750-1758
112. Wilson J.N., Nokes D.J., and Carman W.F. The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern?. Vaccine 17 7-8 (1999) 973-978
113. Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Yotsumoto S., Okamoto H., Miyakawa Y., and Mayumi M. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 68 4 (1994) 2671-2676
114. Yuan T.T., Lin M.H., Qiu S.M., and Shih C. Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation. J. Virol. 72 3 (1998) 2168-2176
115. Zhou T., Saputelli J., Aldrich C.E., Deslauriers M., Condreay L.D., and Mason W.S. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine [in Process Citation]. Antimicrob. Agents Chemother. 43 8 (1999) 1947-1954
116. Zollner B., Petersen J., Schroter M., Laufs R., Schoder V., and Feucht H.H. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet 357 9260 (2001) 934-935
117. Zoulim F., Zhang X., Pichoud C., and Trepo C. Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc. J. Hepatol. 24 2 (1996) 155-160